Evidence map›Paper›PMID 39595041›Full record

ArticleBiomedicines2024

Prognostic Significance and Treatment Response Associations of Genetic Mutations in Chronic Myelomonocytic Leukemia: A Retrospective Cohort Study.

Jing Di, Leonard N Yenwongfai, Talal Arshad, Bin Huang, Jaclyn K McDowell, Eric B Durbin, Reinhold Munker, Sainan Wei

Abstract read
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Contemporary CMML Risk Stratification and Management.Current hematologic malignancy reports · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jing DiDepartment of Pathology & Laboratory Medicine, University of Kentucky, Lexington, KY 40536, USA.ORCID 0000-0001-5637-8748
Leonard N YenwongfaiDepartment of Pathology & Laboratory Medicine, University of Kentucky, Lexington, KY 40536, USA.
Talal ArshadDepartment of Pathology & Laboratory Medicine, University of Kentucky, Lexington, KY 40536, USA.
Bin HuangDivision of Cancer Biostatistics, University of Kentucky, Lexington, KY 40536, USA.
Jaclyn K McDowellMarkey Cancer Center, Cancer Research Informatics Shared Resource Facility, University of Kentucky, Lexington, KY 40536, USA.
Eric B DurbinKentucky Cancer Registry, Lexington, KY 40504, USA.ORCID 0000-0002-5600-7645
Reinhold MunkerDivision of Hematology, Blood and Marrow Transplantation, University of Kentucky, Lexington, KY 40536, USA.
Sainan WeiDepartment of Pathology & Laboratory Medicine, University of Kentucky, Lexington, KY 40536, USA.ORCID 0000-0001-9394-186X

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Jennifer F Rogers · 2013 to 2026
$38.3M
NCI NIH HHS P30 CA177558
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic myelomonocytic leukemiagenetic profilingprognostic biomarkerssurvival analysis

Identifiers

PMID39595041
PMCPMC11591710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.